DA
DSC Advisors’s Zevra Therapeutics ZVRA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-49,100
| Closed | -$250K | – | 30 |
|
|
2023
Q2 | $250K | Buy |
+49,100
| New | +$250K | 0.38% | 17 |
|
|
2020
Q2 | – | Sell |
-4,095,914
| Closed | -$922K | – | 33 |
|
|
2020
Q1 | $922K | Hold |
4,095,914
| – | – | 0.9% | 10 |
|
|
2019
Q4 | $1.55M | Hold |
4,095,914
| – | – | 0.74% | 20 |
|
|
2019
Q3 | $2.82M | Hold |
4,095,914
| – | – | 0.56% | 17 |
|
|
2019
Q2 | $7.17M | Hold |
4,095,914
| – | – | 1.26% | 11 |
|
|
2019
Q1 | $6.84M | Hold |
4,095,914
| – | – | 1.26% | 12 |
|
|
2018
Q4 | $7.29M | Buy |
4,095,914
+2,000,000
| +95% | +$3.56M | 0.88% | 11 |
|
|
2018
Q3 | $10.1M | Buy |
2,095,914
+304,283
| +17% | +$1.46M | 1.35% | 9 |
|
|
2018
Q2 | $11.6M | Hold |
1,791,631
| – | – | 1.89% | 6 |
|
|
2018
Q1 | $14.2M | Hold |
1,791,631
| – | – | 2.96% | 3 |
|
|
2017
Q4 | $7.26M | Hold |
1,791,631
| – | – | 4.21% | 6 |
|
|
2017
Q3 | $6.63M | Buy |
1,791,631
+332,438
| +23% | +$1.23M | 2.11% | 9 |
|
|
2017
Q2 | $5.84M | Hold |
1,459,193
| – | – | 1.92% | 10 |
|
|
2017
Q1 | $7.15M | Hold |
1,459,193
| – | – | 4.87% | 9 |
|
|
2016
Q4 | $4.31M | Buy |
1,459,193
+515,708
| +55% | +$1.52M | 2.44% | 16 |
|
|
2016
Q3 | $4.24M | Hold |
943,485
| – | – | 2.57% | 16 |
|
|
2016
Q2 | $3.76M | Buy |
943,485
+49,927
| +6% | +$199K | 2.36% | 16 |
|
|
2016
Q1 | $13M | Buy |
893,558
+92,301
| +12% | +$1.34M | 7.7% | 3 |
|
|
2015
Q4 | $15.9M | Buy |
801,257
+176,357
| +28% | +$3.5M | 8.31% | 3 |
|
|
2015
Q3 | $12.1M | Buy |
624,900
+80,257
| +15% | +$1.56M | 5.88% | 5 |
|
|
2015
Q2 | $10M | Buy |
+544,643
| New | +$10M | 5.2% | 6 |
|